Performance, transparency, trust

We’re proud of the value we create for all our stakeholders, and strive to communicate our performance in a clear and timely manner. Download the latest reports, or stay up to date on various metrics of our market performance here. If you have any queries not addressed here, please feel free to get in touch with Investor Relations on our Contact page. 

Investors

Observe Medical ASA was listed on Oslo Børs 4 November 2019. Our ambition is to provide shareholders, analysts and investors simultaneous access to accurate, clear and relevant information. We aim to make all our communication to the financial market available on this web site. 

Read our latest regulatory news

OBSERVE MEDICAL ASA: KEY INFORMATION RELATING TO THE PREFERENTIAL RIGHTS ISSUE

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END…

Read more

Observe Medical ASA: Q1 2020 financial results

Oslo, 12 May 2020 – Observe Medical ASA (OSE: OBSERV) today released its presentation of the first quarter 2020, including an updated market study indicating a doubling of the potential market value for the company’s first product, Sippi®. The company’s long term revenue ambition for Sippi® is increased accordingly to NOK 500 million. “During the…

Read more

Financial calendar

  • 30.4.20

    Annual Report

  • 12.05.20

    Quarterly Presentation – Q1

  • 30.06.20

    Annual General Meeting

  • 18.08.20

    Half-yearly Report

  • 03.11.20

    Quarterly Presentation – Q3

The Share

Share performance

Shareholders

Last updated 18 May 2020

NameNumber of shares% of top 20% of totalCountry
1NAVAMEDIC ASA3 200 000 24,30%20,86%Norway
2INGERØ REITEN INV. COMPANY AS2 916 667 22,15%19,01%Norway
3UBS SWITZERLAND AG1 420 522 10,79%9,26%Switzerland
4RO, LARS1 300 0009,87%8,47%Norway
5ALPINE CAPITAL AS645 0004,90%4,20%Norway
6ARTAL AS560 0674,25%3,65%Norway
7SOLEGLAD INVEST AS541 668 4,11%3,53%Norway
8TRANBERGKOLLEN INVEST AS491 666 3,73%3,20%Norway
9LEIKERANE AS466 666 3,54%3,04%Norway
10NORDA ASA407 8293,10%2,66%Norway
11LAPAS AS266 0002,02%1,73%Norway
12KRAEBER VERWALTUNG GMBH214 850 1,63%1,40%Germany
13BUKKEVIK INVESTERING AS140 0001,06%0,91%Norway
14LID, OLAV TARJEI HIORTH114 500 0,87%0,75%Norway
15MK PENSJON PK100 0250,76%0,65%Norway
16EILERAAS, KARL ANSKAR 86 4910,66%0,56%Norway
17GINNY INVEST AS 83 3490,63%0,54%Norway
18BJØRNTVEDT, VEGARD 75 080 0,57%0,49%Norway
19BJØRNTVEDT, EIVIND 71 0760,54%0,46%Norway
20GRAFISK PAPIR AS 65 0000,49%0,42%Norway
Total numer owned by top 2013 166 456100,00%85,82%
Total number of shares15 342 673

Basic share data

Stock Exchange:

Ticker:

First day of listing:

Sector:

Trading Currency:

ISIN:

Number of shares issued:

Nominal value:

Oslo Axess

OBSERV

4 November 2019

Healthcare

NOK

NO0010865009

15 342 673

NOK 0.26

 

Nomination committee

The Articles of Association provide for a nomination committee composed of two or three members. The current members of the nomination committee are Bernt Olav Røttingsnes (chair) and Grete Hogstad.

The nomination committee is responsible for nominating candidates for the election of shareholder-elected members and chairperson to the Board of Directors and for nominating members to the nomination committee, as well as making recommendations for remuneration of these. 

For nomination committee please contact: 

Björn Larsson, Chief Executive Officer
+46 766 201 725 / bjorn.larsson@observemedical.com

 

IR contact

Björn Larsson, Chief Executive Officer
+46 766 201 725 / bjorn.larsson@observemedical.com

Per Arne Nygård, Chief Financial Officer
+47 41 10 43 45 / perarne.nygard@observemedical.com

Sign up for the mailing list